MindMaze Therapeutics Holding S.A. Sponsored ADR
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RLFTY research report →
Companywww.mindmazetherapeutics.com
MindMaze Therapeutics Holding SA engages in the development of AI-powered neurotherapeutics and pharmacological treatments for brain disorders. It focuses on addressing neurological and neuropsychiatric conditions through advanced research, clinical development, and technology-driven solutions. The company is headquartered in Geneva, Switzerland.
- CEO
- Zach W. Henderson
- IPO
- 2021
- Employees
- 31
- HQ
- Geneva, CH
Price Chart
Growth & Income
- Revenue
- $642.00K · -92.37%
- Net Income
- $-9,906,000 · 42.13%
- EPS
- $-0.79 · 42.34%
- Op Income
- $-10,515,000
- FCF YoY
- -134.13%
Performance & Tape
- 52W High
- $4.05
- 52W Low
- $0.27
- 50D MA
- $1.52
- 200D MA
- $1.87
- Beta
- 0.68
- Avg Volume
- 41
Get TickerSpark's AI analysis on RLFTY
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our RLFTY Coverage
We haven't published any research on RLFTY yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate RLFTY Report →